Td Asset Management Inc Black Diamond Therapeutics, Inc. Transaction History
Td Asset Management Inc
- $114 Billion
- Q3 2025
A detailed history of Td Asset Management Inc transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 183,420 shares of BDTX stock, worth $772,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183,420
Previous 165,678
10.71%
Holding current value
$772,198
Previous $410,000
64.88%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BDTX
# of Institutions
97Shares Held
41.5MCall Options Held
68.7KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.7MShares$45.2 Million0.02% of portfolio
-
Vestal Point Capital, LP New York, NY5.55MShares$23.4 Million0.95% of portfolio
-
Nea Management Company, LLC Timonium, MD4.45MShares$18.7 Million1.03% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$13.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.19MShares$9.22 Million0.0% of portfolio
About Black Diamond Therapeutics, Inc.
- Ticker BDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,339,500
- Market Cap $153M
- Description
- Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...